These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20588003)

  • 1. The harmful role of c5a on innate immunity in sepsis.
    Ward PA
    J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-complement strategies in experimental sepsis.
    Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
    Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the complement in experimental sepsis.
    Ward PA
    J Leukoc Biol; 2008 Mar; 83(3):467-70. PubMed ID: 17875813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-induced impairment of innate immunity during sepsis.
    Huber-Lang MS; Younkin EM; Sarma JV; McGuire SR; Lu KT; Guo RF; Padgaonkar VA; Curnutte JT; Erickson R; Ward PA
    J Immunol; 2002 Sep; 169(6):3223-31. PubMed ID: 12218141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of innate immunity by C5aR antagonist in septic mice.
    Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
    FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation.
    Bosmann M; Haggadone MD; Zetoune FS; Sarma JV; Ward PA
    Eur J Immunol; 2013 Jul; 43(7):1907-13. PubMed ID: 23575697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a regulates NKT and NK cell functions in sepsis.
    Fusakio ME; Mohammed JP; Laumonnier Y; Hoebe K; Köhl J; Mattner J
    J Immunol; 2011 Dec; 187(11):5805-12. PubMed ID: 22058413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a functional role of the second C5a receptor C5L2.
    Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
    FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
    Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
    Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
    J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
    FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions.
    Wrann CD; Tabriz NA; Barkhausen T; Klos A; van Griensven M; Pape HC; Kendoff DO; Guo R; Ward PA; Krettek C; Riedemann NC
    J Immunol; 2007 May; 178(9):5940-8. PubMed ID: 17442978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a, a therapeutic target in sepsis.
    Guo RF; Ward PA
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γδT-cell function in sepsis is modulated by C5a receptor signalling.
    Han G; Geng S; Li Y; Chen G; Wang R; Li X; Ma Y; Shen B; Li Y
    Immunology; 2011 Jul; 133(3):340-9. PubMed ID: 21501163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.
    Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO
    Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
    Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
    J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of C5a receptors.
    Ward PA
    J Mol Med (Berl); 2009 Apr; 87(4):375-8. PubMed ID: 19189071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
    Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
    FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.